DJIA 17,001.22 -38.27 -0.22%
NASDAQ 4,538.55 6.45 0.14%
S&P 500 1,988.40 -3.97 -0.20%
market minute promo

Transcept Pharmaceuticals (NASDAQ: TSPT)

2.22 0.01 (0.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TSPT $2.22 0.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.20
Previous Close $2.21
Daily Range $2.20 - $2.26
52-Week Range $1.85 - $3.90
Market Cap $42.5M
P/E Ratio -2.57
Dividend (Yield) $0.00 (0.0%)
Volume 110,251
Average Daily Volume 87,577
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

Transcept Pharmaceuticals (TSPT) Description

Transcept Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience. Website: http://www.transcept.com/

News & Commentary

Can't Sleep? Don't Worry, You're Not Alone

Roughly 100 million people in the U.S. exhibit signs of insomnia each year, but many of the treatments available to treat this disorder have been nothing short of a disappointment.

Sector Update: Healthcare Stocks Stretching Out Gains Near Finish Line; Transcept Pharma Jumps Over

Sector Update: Healthcare Stocks Stretching Out Gains Near Finish Line; Transcept Pharma Jumps Over 20% Following $333 Mln Deal with Privately Held Rival

Sector Update: Healthcare

Benzinga's Top #PreMarket Gainers

Morning Market Losers

Transcept Pharmaceuticals, Inc. (TSPT) Ex-Dividend Date Scheduled for June 04, 2014

Transcept Pharmaceuticals Issues Statement on Dismissal of Derivative Lawsuit

Transcept Pharmaceuticals Statement on the Withdrawal of Retrophin's $4.00/Share Offer

Transcept Pharmaceuticals Announces Roumell Asset Management Supports Company Strategies

Transcept Provides Update to Key Initiatives to Increase Stockholder Value

Transcept Pharmaceuticals' CEO Discusses Q3 2013 Results - Earnings Call Transcript

See More TSPT News...

TSPT's Top Competitors

TSPT $2.22 (0.45%)
Current stock: TSPT
AMGN $132.82 (0.22%)
Current stock: AMGN
GILD $103.96 (1.65%)
Current stock: GILD
BIIB $339.97 (0.39%)
Current stock: BIIB